No black box warning on record for Alunbrig

As of the latest FDA labeling reviewed, Alunbrig (BRIGATINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Alunbrig medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Interstitial Lung Disease (ILD)/Pneumonitis : Monitor for new or worsening respiratory symptoms, particularly during the first week of treatment. Withhold ALUNBRIG for new or worsening respiratory symptoms and promptly evaluate for ILD/pneumonitis. Upon recovery, either dose reduce or permanently discontinue ALUNBRIG. ( 2.3 , 5.1 ) Hypertension : Monitor blood pressure a

No black box warning on record for Alunbrig

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Interstitial Lung Disease (ILD)/Pneumonitis : Monitor for new or worsening respiratory symptoms, particularly during the first week of treatment. Withhold ALUNBRIG for new or worsening respiratory symptoms and promptly evaluate for ILD/pneumonitis. Upon recovery, either dose reduce or permanently discontinue ALUNBRIG. ( 2.3 , 5.1 ) Hypertension : Monitor blood pressure a

Alunbrig Black Box Warning

No black box warning on record for Alunbrig

Other warnings & precautions

Alunbrig Black Box Warning

No black box warning on record for Alunbrig

Other warnings & precautions